Align Technology, Inc. (0HCK.L)
USD 167.1
(2.38%)
USD 167.1
(2.38%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 799.03 Million USD | -1.4% |
| 2022 | 755.37 Million USD | -27.12% |
| 2021 | 1.11 Billion USD | 120.99% |
| 2020 | 503.13 Million USD | -18.57% |
| 2019 | 666.02 Million USD | 18.52% |
| 2018 | 521.29 Million USD | 33.2% |
| 2017 | 391.35 Million USD | 43.39% |
| 2016 | 272.92 Million USD | 32.08% |
| 2015 | 206.63 Million USD | -2.27% |
| 2014 | 211.43 Million USD | 18.75% |
| 2013 | 109.96 Million USD | 26.55% |
| 2012 | 102.1 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 165.93 Million USD | -22.59% |
| 2024 Q1 | 187.08 Million USD | -9.29% |
| 2024 Q2 | 214.33 Million USD | 14.57% |
| 2023 Q4 | 218.23 Million USD | 7.3% |
| 2023 FY | - USD | -1.4% |
| 2023 Q1 | 177.09 Million USD | 6.95% |
| 2023 Q2 | 215.52 Million USD | 21.7% |
| 2023 Q3 | 203.37 Million USD | -5.64% |
| 2022 Q4 | 165.58 Million USD | -9.78% |
| 2022 Q3 | 183.52 Million USD | -18.8% |
| 2022 FY | - USD | -27.12% |
| 2022 Q1 | 235.23 Million USD | -8.55% |
| 2022 Q2 | 226.02 Million USD | -3.91% |
| 2021 Q3 | 295.72 Million USD | -1.85% |
| 2021 Q4 | 257.22 Million USD | -13.02% |
| 2021 Q1 | 251.08 Million USD | 5.52% |
| 2021 Q2 | 301.29 Million USD | 20.0% |
| 2021 FY | - USD | 120.99% |
| 2020 Q1 | 90.65 Million USD | -47.58% |
| 2020 Q3 | 201.55 Million USD | 507.55% |
| 2020 FY | - USD | -18.57% |
| 2020 Q4 | 237.95 Million USD | 18.06% |
| 2020 Q2 | -49.45 Million USD | -154.55% |
| 2019 FY | - USD | 18.52% |
| 2019 Q4 | 172.94 Million USD | 23.47% |
| 2019 Q3 | 140.06 Million USD | -3.18% |
| 2019 Q1 | 135.79 Million USD | -5.05% |
| 2019 Q2 | 144.66 Million USD | 6.53% |
| 2018 Q2 | 135.32 Million USD | 23.44% |
| 2018 Q1 | 109.62 Million USD | -13.56% |
| 2018 FY | - USD | 33.2% |
| 2018 Q4 | 143.01 Million USD | 2.65% |
| 2018 Q3 | 139.32 Million USD | 2.96% |
| 2017 Q4 | 126.83 Million USD | 16.64% |
| 2017 Q1 | 69.54 Million USD | -8.0% |
| 2017 FY | - USD | 43.39% |
| 2017 Q2 | 92.44 Million USD | 32.94% |
| 2017 Q3 | 108.73 Million USD | 17.62% |
| 2016 Q2 | 70.22 Million USD | 20.82% |
| 2016 Q1 | 58.12 Million USD | -9.46% |
| 2016 Q3 | 68.98 Million USD | -1.78% |
| 2016 FY | - USD | 32.08% |
| 2016 Q4 | 75.58 Million USD | 9.58% |
| 2015 Q2 | 46.65 Million USD | -12.36% |
| 2015 Q4 | 64.2 Million USD | 50.89% |
| 2015 FY | - USD | -2.27% |
| 2015 Q3 | 42.54 Million USD | -8.8% |
| 2015 Q1 | 53.23 Million USD | -4.74% |
| 2014 FY | - USD | 18.75% |
| 2014 Q2 | 53.08 Million USD | 13.97% |
| 2014 Q1 | 46.58 Million USD | -18.42% |
| 2014 Q4 | 55.88 Million USD | -0.01% |
| 2014 Q3 | 55.88 Million USD | 5.27% |
| 2013 Q2 | 41.74 Million USD | 23.21% |
| 2013 FY | - USD | 26.55% |
| 2013 Q1 | 33.88 Million USD | -3.37% |
| 2013 Q3 | 45.32 Million USD | 8.57% |
| 2013 Q4 | 57.1 Million USD | 25.99% |
| 2012 Q4 | 35.06 Million USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 876.18% |
| Accuray Incorporated | 9 Million USD | -8769.342% |
| Elevance Health Inc. | 10.49 Billion USD | 92.383% |
| AxoGen, Inc. | -13.32 Million USD | 6095.191% |
| Boston Scientific Corporation | 3.61 Billion USD | 77.884% |
| CVS Health Corporation | 18.17 Billion USD | 95.604% |
| Cardinal Health, Inc. | 1.97 Billion USD | 59.604% |
| Centene Corporation | -463 Million USD | 272.579% |
| DaVita Inc. | 2.34 Billion USD | 65.947% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 93.719% |
| Hologic, Inc. | 1.29 Billion USD | 38.355% |
| Humana Inc. | -561 Million USD | 242.431% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 34.379% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | 40.786% |
| Masimo Corporation | 236.7 Million USD | -237.575% |
| McKesson Corporation | 4.66 Billion USD | 82.879% |
| Patterson Companies, Inc. | 374.75 Million USD | -113.216% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | 53.866% |
| ResMed Inc. | 1.6 Billion USD | 50.07% |
| Henry Schein, Inc. | 943 Million USD | 15.266% |
| Teladoc Health, Inc. | 153.99 Million USD | -418.867% |
| Universal Health Services, Inc. | 1.74 Billion USD | 54.168% |
| Veeva Systems Inc. | 429.33 Million USD | -86.111% |
| Baxter International Inc. | 2.77 Billion USD | 71.216% |
| Becton, Dickinson and Company | 4.27 Billion USD | 81.309% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 66.625% |
| Danaher Corporation | 7.49 Billion USD | 89.345% |
| Stryker Corporation | 5.16 Billion USD | 84.515% |
| Medtronic plc | 9.05 Billion USD | 91.177% |